Resultados de la búsqueda 581-590 of 19080 for Two-phase

  1. Neurología - Ensayos clínicos - Mayo Clinic

    This randomized phase III trial compares memantine hydrochloride and whole ... 2-year progression free survival (PFS) rate as compared to ACNS0122.

  2. Cáncer de colon en etapa 4 (metastásico) - Médicos y departamentos - Mayo Clinic

    Ir a página 22 · SiguientePróxima página. Investigación. Los médicos y los investigadores de Mayo Clinic que se dedican a la investigación del cáncer ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

  4. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to determine the maximum tolerated dose (MTD) and schedule and/or a recommended Phase 2 ... phase II dose (RP2D of APG2575 in ...

  5. Oncología (médica) - Ensayos clínicos

    This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

  6. Oncología (médica) - Ensayos clínicos

    This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

  7. Plexiform neurofibroma - Diagnósticos y tratamientos - Mayo Clinic

    Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: A phase 2 trial. Nature Medicine. 2025; doi:10.1038/s41591‑024‑03361‑4. Fisher MJ, et ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic ...

  9. Oncología (médica) - Ensayos clínicos

    This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations. It efficiently examines a ...